For research use only
| Cat No. | ABC-TC130G |
| Product Type | Bronchial Cells |
| Cell Type | Epithelial Cells |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bronchial |
| Disease | Non Cystic Fibrosis Bronchiectasis |
| Storage | Liquid Nitrogen |
Primary human bronchial epithelial cells from non-cystic fibrosis bronchiectasis donors, supplied for airway disease and inflammation research.
Human Bronchial Epithelial Cells–Non Cystic Fibrosis Bronchiectasis are isolated from bronchial airway tissue obtained from donors diagnosed with non-cystic fibrosis bronchiectasis. Bronchial epithelial cells form the first line of defense in the respiratory tract and play important roles in mucociliary clearance, innate immunity, and airway barrier function. Following primary isolation and culture, the cells are cryopreserved for research applications. These cells have been reported to express epithelial markers including CK18, CK19, E-cadherin, and EpCAM. In vitro, the cells exhibit a characteristic cobblestone-like morphology and grow as an adherent monolayer. They are widely used for studies of airway inflammation, host-pathogen interactions, mucosal immunity, and chronic respiratory diseases. Each lot undergoes extensive screening procedures and is tested for the absence of mycoplasma, fungi, yeast, and bacterial contamination.
| Product Code | Non-CFBE Cells, Bronchiectatic Airway Cells, Diseased Airway Epithelium |
| Species | Human |
| Cat.No | ABC-TC130G |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial Cells |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bronchial |
| Disease | Non Cystic Fibrosis Bronchiectasis |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Bronchial Cells |
| Quality Control | Each lot tests negative for mycoplasma, bacteria, yeast, and fungi. |
Human Bronchial Epithelial Cells-Non Cystic Fibrosis Bronchiectasis are suitable for airway disease research, bronchiectasis pathogenesis studies, respiratory infection models, inflammatory signaling investigations, drug screening, toxicology assessments, and evaluation of airway epithelial barrier function.